Advertisement
Screener

Five Prime Therapeutics, Inc. Form 10-Q/A: Amended quarterly report

Five Prime Therapeutics, Inc. Form 10-Q/A: Amended quarterly report

Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.

  • 2014-08-26: Form 10-Q/A; Period of report 2014-03-31; Description AMENDMENT NO.1 TO FORM 10-Q; Document d778761d10qa.htm.
FiledFormPeriod of reportDescriptionDocument
2014-08-2610-Q/A2014-03-31AMENDMENT NO.1 TO FORM 10-Qd778761d10qa.htm